JAK2-STAT3 was overexpressed in the CRC stem cell, and the targeting gene cyclin D2 (CCND2) was increasingly transcribed to maintain the properties of CRC CSCs, such as proliferation and radio-resistance [86]. This evidence concerns the gene JAK2 and colorectal carcinoma.